A study proposed that prostate cancer can be divided into different molecular subtypes, including mutually exclusive cancers with positive E-26 transformation-specific (ETS) gene fusion, overexpression of SPINK1, and E-cadherin deletion. This evidence concerns the gene SPINK1 and prostate carcinoma.